San Diego, United States
Illumina, founded in 1998, is a trailblazer in the Biotechnology industry, headquartered in the United States. With its slogan, "Unlocking the Power of the Genome," the company is committed to advancing the analysis of genetic variation and function, crucial for the progress of personalized medicine.
Illumina leverages innovative, array-based solutions to provide comprehensive tools for DNA, RNA, and protein analysis, catalyzing breakthroughs in disease research, drug development, and molecular testing. Their solutions emphasize flexibility, scalability, and robust support, responding to the rapid technological advancements in genomics.
Recently, Illumina secured a significant $500.00M post-IPO debt investment, showcasing investor confidence in their growth trajectory. This capital infusion could further bolster their competitive edge, strengthening their global presence and innovation in the biotech space.
